 CohBar, Inc. CWBR, a clinical stage biotechnology company developing mitochondria based therapeutics to treat chronic diseases and extend healthy lifespan, today announced its Chief Executive Officer, Steven Engle will be a participant on the panel titled Redefining What it Means to Get Old: New Breakthroughs in Aging Biology at the BIO 2020 Digital Conference, to be held on June 8-12, 2020. The panel, featuring Nathaniel David, Co-Founder and President of Unity Biotechnology, Tom Hughes, CEO of Navitor Pharmaceuticals and Steven Engle, CEO of CohBar, will be moderated by Hannah Kuchler, US Pharma and Biotech Correspondent for the Financial Times. 